CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Restylane® Defynedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03273543
NCT03273543N/ACompleted
CompareCT.gov

Premaxillary Injection for Perioral Rejuvenation and Upper Lip Enhancement

DeNova Research·interventional·Posted Sep 6, 2017·Updated Oct 8, 2020

In Brief

A clinical study evaluating Restylane® Defyne for Perioral Rejuvenation and Upper Lip Projection. Completed, enrolled 20 participants across 1 site.

Detailed Summary

To determine if subjects who receive premaxillary injection demonstrate an increase in nasal tip projection and an associated increase in upper lip projection, and vermillion height.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPerioral Rejuvenation, Upper Lip Projection
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 6, 2017
Enrollment StartNov 20, 2017
Primary CompletionJul 3, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.8 years ago

Interventions

Restylane® Defynedevice

hyaluronic acid filler injection